Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
2020 · Cardiovascular Diabetology · 112 citations
https://doi.org/10.1186/s12933-019-0977-z